Bacterial Infections and Mycoses

318 trials 133 recruiting

Filter these 318 trials by phase, country and sponsor.

Open in Search →

Phase 1 study in Staphylococcus aureus endocarditis Ended

2023-505413-25-00 Infectious S. aureus endocarditis 3 2024-04-10
A study to investigate the pharmacokinetics of a combined oral contraceptive when given alone and in combination with GSK3036656 in female p… Ended

2023-507839-38-00 Tuberculosis 3 2024-04-05
Safety and Immunogenicity of V116 in Children and Adolescents With Increased Risk for Pneumococcal Disease Ended

2023-506236-32-00 Pneumococcal disease 5 2024-03-25
A Phase 3 study to assess efficacy and safety of oral tebipenem compared to IV imipenem-cilastatin in adults with cUTI/AP Ended

2023-503785-22-00 complicated urinary tract infection (cUTI) or acute pye 5 2024-03-25
A pilot single center, open label trial to assess the impact of doxycycline postexposure prophylaxis on antimicrobial resistance (SafeDoxyPE… Ended

2023-507137-24-00 Bacterial sexually transmittable diseases (chlamydia, g 4 2024-03-13
Study on immunogenicity and safety of a meningococcal ACYW conjugate vaccine in healthy infants and toddlers Ended

2023-508177-85-00 Healthy volunteers (Meningococcal infection) 5 2024-03-12
Vancomycin treatment in critically ill adults using model-informed precision dosing tool – prospective low-intervention clinical trial. (Pro… Ended

2023-509003-32-00 Serious infections where according to the treating phys 6 2024-03-01
SAFE study: Stopping Antibiotics after 3 days for the treatment of FEbrile Neutropenia in Haematology patients, a randomized open-label non-… Ended

2022-500389-84-00 Febrile neutropenia 6 2024-02-16
RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BAS… Ended

2023-509075-17-00 Bacilliferous pulmonary tuberculosis 4 2024-01-17
COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit Ended

2023-505108-52-00 Intensive Care 5 2023-12-20
Clindamycin pharmacokinetics during obstetric or fetal surgery Ended

2023-503653-35-00 Prophylaxis (antibiotics) during maternal or fetal surg 6 2023-12-11
ITPP as an adjunctive treatment for progressive respiratory failure in COVID-19 and other pulmonary parenchymal infections [BREATH2] Ended

2024-517878-21-00 COVID-19 and other pulmonary parenchyma infections. 4 2023-11-28
Pharmacokinetics study of Cefazolin in haemodialysis Ended

2023-506734-73-00 Chronic haemodialysis patients suffering from infection 6 2023-11-20
A Phase 3 Randomized Double-blind Controlled Study to Evaluate the Immunogenicity, Safety, and Reactogenicity of ExPEC9V and High-dose Quadr… Ended

2023-504168-40-00 Prevention of invasive extraintestinal pathogenic Esche 5 2023-11-06
A Phase 2 Safety and Immunogenicity Study of a Monovalent Pneumococcal Conjugate Candidate in Healthy Toddlers Ended

2023-505154-18-00 Pneumococcal Infections 4 2023-11-02
A Study to Investigate MBS2320 Patients with IPF Ended

2023-504418-30-00 Idiopathic Pulmonary Fibrosis 4 2023-10-24
A study to test whether spesolimab helps people with a skin disease called hidradenitis suppurativa Ended

2022-501074-19-00 Hidradenitis suppurativa 10 2023-10-13
A Single Dose, Fed state, Crossover Replicate Bioequivalence Study of NITROFURANTOIN 100 mg prolonged-release capsules (Iasis Pharma) vs. FU… Ended

2023-503887-18-00 healthy subjects 2 2023-10-02
Safety and efficacy of GSK Neisseria gonorrhoeae GMMA (NgG) investigational vaccine when administered to healthy adults 18 to 50 years of ag… Ended

2022-500883-37-00 This FTiH-PoC study aims to provide an early evaluation 7 2023-10-02
Randomized, Open-label, Single-Dose, Two-treatment, Two-period, Cross-over, Pivotal Bioequivalence Study Comparing Amoxicilin/Clavulanic aci… Ended

2023-503233-22-00 Not applicable (submitted trial is a bioequivalence stu 2 2023-09-27
A double-blind, randomised, dose-finding trial to assess the efficacy, safety and pharmacokinetics of a single dose of albaconazole versus f… Ended

2023-504727-32-00 Acute vulvovaginal candidiasis 4 2023-09-18
Maternal determinants of infant immunity to pertussis (MADI-02) Ended

2024-517893-73-00 Whooping cough 6 2023-09-09
A three part randomized, double-blind, placebo-controlled, parallel group SAD and MD clinical study to evaluate the safety, tolerability and… Ended

2023-507203-55-00 Pseudomonas colonization 1 2023-08-21
A randomized trial investigating the superiority of TDM-optimized teicoplanin dosing versus standard of care Ended

2023-503411-15-00 Sepsis 6 2023-08-17